Surgical Bleeding Control of Extra-corporeal Circulation (ECC) by Vacuum Devices (HEMOCARD)
Primary Purpose
Bleeding
Status
Completed
Phase
Phase 1
Locations
France
Study Type
Interventional
Intervention
cardiac surgery requiring ECC
Sponsored by

About this trial
This is an interventional treatment trial for Bleeding focused on measuring cardiac surgery requiring ECC
Eligibility Criteria
Inclusion Criteria:
- more or equal than 18 years old
- patient affiliated to social security or similarly regime
- patient sent to hospital for cardiac surgery requiring ECC
Exclusion Criteria:
- Pregnant women and lactating mothers
- Ward of court or under guardianship
- Adult unable to express their consent
- Person deprived of freedom by judicial or administrative decision
- Person hospitalized without their consent
- Person under legal protection
- Person participating in another clinical study
Sites / Locations
- UniversityHospitalGrenoble
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
vacuum device - suction cup
Arm Description
Outcomes
Primary Outcome Measures
Persistence or absence of bleeding extraMD at the orifice of the retrograde cannulation when the suction cup is in place.
Secondary Outcome Measures
Persistence or absence of bleeding intraMD at the orifice of the retrograde cannulation when the suction cup is in place.
Persistence or absence of bleeding at the orifice of the retrograde cannulation when the vacuum was removed.
Persistence or absence of bleeding extraMD at the orifice of the aortic purge when the suction cup is in place.
Persistence or absence of bleeding extraMD at the orifice of the aortic purge when the suction cup is in place.
Persistence or absence of bleeding at the orifice of the aortic purge when the vacuum was removed.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT00843596
Brief Title
Surgical Bleeding Control of Extra-corporeal Circulation (ECC) by Vacuum Devices
Acronym
HEMOCARD
Study Type
Interventional
2. Study Status
Record Verification Date
February 2012
Overall Recruitment Status
Completed
Study Start Date
October 2009 (undefined)
Primary Completion Date
December 2011 (Actual)
Study Completion Date
December 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
AdministrateurCIC
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
the purpose of this study is to show that the vacuum control surgical bleeding helps stop bleeding extraMD (MD: Medical Device) at the orifice of the retrograde cannulation during a heart with Extra-corporeal circulation (ECC),
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bleeding
Keywords
cardiac surgery requiring ECC
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 1, Phase 2
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
30 (Actual)
8. Arms, Groups, and Interventions
Arm Title
vacuum device - suction cup
Arm Type
Experimental
Intervention Type
Procedure
Intervention Name(s)
cardiac surgery requiring ECC
Intervention Description
the vacuum device is left on the 2 wounds (caused by the ECC cannulas) for 15 min (possible a second time of 15 min : 30 min max.)
Primary Outcome Measure Information:
Title
Persistence or absence of bleeding extraMD at the orifice of the retrograde cannulation when the suction cup is in place.
Time Frame
20-30 min
Secondary Outcome Measure Information:
Title
Persistence or absence of bleeding intraMD at the orifice of the retrograde cannulation when the suction cup is in place.
Time Frame
20-30 min
Title
Persistence or absence of bleeding at the orifice of the retrograde cannulation when the vacuum was removed.
Time Frame
20-30 min
Title
Persistence or absence of bleeding extraMD at the orifice of the aortic purge when the suction cup is in place.
Time Frame
20- 30 min
Title
Persistence or absence of bleeding extraMD at the orifice of the aortic purge when the suction cup is in place.
Time Frame
20 -30 min
Title
Persistence or absence of bleeding at the orifice of the aortic purge when the vacuum was removed.
Time Frame
20 -30 min
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
more or equal than 18 years old
patient affiliated to social security or similarly regime
patient sent to hospital for cardiac surgery requiring ECC
Exclusion Criteria:
Pregnant women and lactating mothers
Ward of court or under guardianship
Adult unable to express their consent
Person deprived of freedom by judicial or administrative decision
Person hospitalized without their consent
Person under legal protection
Person participating in another clinical study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dominique BLIN, MD, PhD
Organizational Affiliation
University Hospital, Grenoble
Official's Role
Principal Investigator
Facility Information:
Facility Name
UniversityHospitalGrenoble
City
Grenoble
Country
France
12. IPD Sharing Statement
Learn more about this trial
Surgical Bleeding Control of Extra-corporeal Circulation (ECC) by Vacuum Devices
We'll reach out to this number within 24 hrs